Association of race and ethnicity with withdrawal symptoms, attrition, opioid use, and side-effects during buprenorphine therapy

Journal of Ethnicity in Substance Abuse

Volumn 9, Issue 2, 2010, Pages 106-114

  Brown, E Sherwood ^a   Tirado, Carlos ^a   Minhajuddin, Abu ^a   Hillhouse, Maureen ^b   Adinoff, Bryon ^a   Ling, Walter ^b   Doraimani, Geetha ^b   Thomas, Christie ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Buprenorphine; Ethnicity; Opioid; Race

Indexed keywords

BUPRENORPHINE; BUPRENORPHINE PLUS NALOXONE;

ADULT; AFRICAN AMERICAN; ARTICLE; CAUCASIAN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSAGE SCHEDULE COMPARISON; DRUG DOSE REGIMEN; DRUG RESPONSE; DRUG TOLERABILITY; ETHNIC DIFFERENCE; FEMALE; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPIATE ADDICTION; PRIORITY JOURNAL; RACE DIFFERENCE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; WITHDRAWAL SYNDROME;

ADULT; AFRICAN AMERICANS; BUPRENORPHINE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; MALE; MIDDLE AGED; NARCOTIC ANTAGONISTS; NATIONAL INSTITUTE ON DRUG ABUSE (U.S.); OPIOID-RELATED DISORDERS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SUBSTANCE WITHDRAWAL SYNDROME; UNITED STATES; YOUNG ADULT;

EID: 77952989534     PISSN: 15332640     EISSN: 15332659     Source Type: Journal    
DOI: 10.1080/15332641003772587     Document Type: Article

References (11)

1. Administration. (2008). Analysis of substance abuse and treatment need issues, table of contents (TOC). Retrieved September 1, 2009, from http://www. drugabusestatistics.samhsa.gov/treatan/toc.htm
2. Bickel,W. K., Stitzer, M. L., Bigelow, G. E., Liebson, I. A., Jasinski, D. R., & Johnson, R. E. (1988). A clinical trial of buprenorphine: Comparisonwithmethadone in the detoxification of heroin addicts. Clinical Pharmacology and Therapeutics, 43, 72-78.
3. Booth, B. M., Blow, F. C., Cook, C. A. L., Bunn, J. Y., & Fortney, J. C. (1992). Age and ethnicity among hospitalized alcoholics: A nationwide study. Alcoholism: Clinical and Experimental Research, 16, 1029-1034.
4. Compton, W. M., Conway, K. P., Stinson, F. S., Colliver, J. D., & Grant, B. F. (2005). Prevalence, correlates, and comorbidity of DSM-IV antisocial personality syndromes and alcohol and specific drug use disorders in the United States: Results from the national epidemiologic survey on alcohol and related conditions. Journal of Clinical Psychiatry, 66, 677-685.
5. Huang, B., Dawson, D. A., Stinson, F. S., Hasin, D. S., Ruan, W. J., Saha, T. D., et al. (2006). Prevalence, correlates, and comorbidity of nonmedical prescription drug use and drug use disorders in the United States: Results of the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry, 67, 1062-1073. (Pubitemid 44230877)
6. Kosten, T. R., & Rayford, B. S. (1995). Effects of ethnicity on low-dose opiate stabilization. Journal of Substance Abuse Treatment, 12(2), 111-116.
7. Ling, W., Hillhouse, M., Domier, C., Doraimani, G., Hunter, J., Thomas, C., et al. (2009). Buprenorphine tapering schedule and illicit opioid use. Addiction, 104, 256-265
8. McCaul, M. E., Svikis, D. S., & Moore, R. D. (2001). Predictors of outpatient treatment retention: Patient versus substance use characteristics. Drug and Alcohol Dependence, 62, 9-17.
9. Mertens, J. R., & Weisner, C. M. (2000). Predictors of substance abuse treatment retention among women and men in an HMO. Alcoholism: Clinical and Experimental Research, 24, 1525-1533.
10. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. (2008, June 3). 6. Prescription drug dependence, abuse, and treatment. Misuse of Prescription Drugs. Retrieved August 28, 2009, from http://www.oas. samhsa.gov/prescription/ch6.htm.
11. Wesson, D. R., & Ling, W. (2003). The Clinical Opiate Withdrawal Scale (COWS). Journal of Psychoactive Drugs, 35, 253-259.